NCT04515836 2025-05-06Olaparib in Patients With HRD Malignant MesotheliomaUniversity of ChicagoPhase 2 Recruiting56 enrolled
NCT03531840 2021-04-09Olaparib in People With Malignant MesotheliomaNational Institutes of Health Clinical Center (CC)Phase 2 Completed23 enrolled 16 charts